NLS Pharmaceutics Company Insiders
| NLSP Stock | USD 1.51 0.01 0.67% |
NLS Pharmaceutics employs about 8 people. The company is managed by 8 executives with a total tenure of roughly 0 years, averaging almost 0.0 years of service per executive, having 1.0 employees per reported executive. Discussion of NLS Pharmaceutics' management performance can provide insight into the enterprise performance.
NLS |
NLS Pharmaceutics Management Team Effectiveness
The company has return on total asset (ROA) of (2.2776) % which means that it has lost $2.2776 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.6292) %, meaning that it created substantial loss on money invested by shareholders. NLS Pharmaceutics' management efficiency ratios could be used to measure how well NLS Pharmaceutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, NLS Pharmaceutics' Return On Capital Employed is relatively stable compared to the past year. As of 03/23/2025, Return On Equity is likely to grow to 1.66, though Return On Tangible Assets are likely to grow to (7.20). As of 03/23/2025, Total Current Liabilities is likely to grow to about 9.6 M. Also, Liabilities And Stockholders Equity is likely to grow to about 3.3 MAs of 03/23/2025, Common Stock Shares Outstanding is likely to grow to about 46.1 M, though Net Loss is likely to grow to (10.2 M).
NLS Pharmaceutics Workforce Comparison
NLS Pharmaceutics AG is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is now estimated at about 855. NLS Pharmaceutics adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
NLS Pharmaceutics Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. NLS Pharmaceutics Price Series Summation is a cross summation of NLS Pharmaceutics price series and its benchmark/peer.
NLS Pharmaceutics Notable Stakeholders
A NLS Pharmaceutics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as NLS Pharmaceutics often face trade-offs trying to please all of them. NLS Pharmaceutics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting NLS Pharmaceutics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Eric MD | CoFounder Officer | Profile | |
| Alexander MBA | CEO President | Profile | |
| Sharon Keys | Head Affairs | Profile | |
| Nicole CPA | Chief Officer | Profile | |
| iur LLM | G Counsel | Profile | |
| Chad MBA | Chief Officer | Profile | |
| Elena ThyenPighin | Chief Officer | Profile | |
| George MD | Chief Development | Profile |
About NLS Pharmaceutics Management Performance
The success or failure of an entity such as NLS Pharmaceutics often depends on how effective the management is. NLS Pharmaceutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of NLS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the NLS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (7.58) | (7.20) | |
| Return On Capital Employed | 1.75 | 1.84 | |
| Return On Assets | (7.58) | (7.20) | |
| Return On Equity | 1.58 | 1.66 |
NLS Pharmaceutics Workforce Analysis
Traditionally, organizations such as NLS Pharmaceutics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare NLS Pharmaceutics within its industry.NLS Pharmaceutics Manpower Efficiency
Return on NLS Pharmaceutics Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 1.5M | |
| Net Loss Per Executive | 1.5M |
Additional Tools for NLS Stock Analysis
When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.